At the news
? BULLISHIMPACT 5/10 COURT-RULING filed Jun 25, 2026 at 20:00 ET
The Delaware Court of Chancery granted Alcon's motion to dismiss all six counts of a stockholder derivative lawsuit challenging Alcon's actions as a controlling stockholder of Aurion Biotech. The court found that the IPO was postponed by an independent Special Committee before Alcon became a controller, and that the complaint failed to plead bad faith against director defendants or viable claims regarding stock transfers. This removes a litigation overhang for Alcon, though the case involved Aurion Biotech, not Alcon's own operations.
- Court granted Alcon's motion to dismiss all six counts of derivative lawsuit with prejudice
- IPO was postponed by an independent Special Committee on Feb 6, 2025, before Alcon became controlling stockholder on Feb 14, 2025
- Court found plaintiff failed to plead bad faith against Alcon-appointed directors or that Frinzi's resignation constituted a fiduciary breach
- Right-of-first-refusal claim dismissed because preferred stock transfers were not 'Transfer Stock' under the agreement and Schedule B was blank
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access